XMAX: financial statements from SEC — TradeAlmanac

XMAX

XMAX, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31 Dec 2025	31 Dec 2024
Revenue	17M	10M
Cost of revenue	13M	5M
Gross profit	4M	4M
Research and development	—	2M
Selling, general and administrative	5M	6M
Operating expenses	6M	10M
Operating income	−2M	−5M
Pre-tax income	−4M	−6M
Income tax	−580,987	2,614
Net income	−3M	−6M
Earnings per share	−0.17	−1.48
Earnings per share, diluted	−0.17	−1.48
Weighted average shares	21M	4M
Weighted average shares, diluted	21M	4M

Balance sheet

Metric	31 Mar 2026	31 Dec 2025	30 Sept 2025	30 Jun 2025	31 Mar 2025	31 Dec 2024	30 Sept 2024	30 Jun 2024
Cash and equivalents	10M	7M	2M	468,825	147,300	161,902	162,285	363,409
Receivables	2M	2M	8M

Cash flow

Metric	31 Dec 2025	31 Dec 2024
Operating cash flow	−445,838	−1M
Depreciation and amortisation	9,912	60,853
Share-based compensation	3M	757,692
Capital expenditure	—	14,121
Investing cash flow	−23M	−14,121
Financing cash flow	30M

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator